🧈 Hypertriglyceridemia Management
This tool directs hypertriglyceridemia management by triglyceride level and ASCVD risk, distinguishing pancreatitis prevention in severe disease from cardiovascular risk reduction in mild-moderate disease.
In severe hypertriglyceridemia the goal is preventing acute pancreatitis, so a fibrate (not a statin alone) leads, alongside a very-low-fat diet and secondary-cause treatment. (original synthesis · not guideline verbatim)
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.
When to use
Use to choose the main line: severe TG (≥ 500 mg/dL) prioritizes a fibrate and very-low-fat diet to prevent pancreatitis, while mild-moderate TG is lifestyle-led with a statin and possible icosapent ethyl.
How it works
Severe (≥ 500 mg/dL) → fibrate + very-low-fat diet + treat secondary causes (± ω-3), statin only after TG < 500. Mild-moderate (150–499) → lifestyle + statin by risk; high-risk on statin with TG ≥ 150 → add icosapent ethyl.
Key points
- In severe hypertriglyceridemia the goal is preventing acute pancreatitis, so a fibrate (not a statin alone) leads, alongside a very-low-fat diet and secondary-cause treatment. (original synthesis · not guideline verbatim)
- Icosapent ethyl (REDUCE-IT) lowers major cardiovascular events ~25% in high-risk patients with persistent TG ≥ 150 on a statin.
- Uncontrolled diabetes, hypothyroidism, alcohol, and certain drugs are common secondary drivers worth correcting first.
References
- Grundy SM, et al. 2018 AHA/ACC Guideline on the Management of Blood Cholesterol. Circulation 2019.
- Virani SS, et al. 2021 ACC Expert Consensus Decision Pathway on Hypertriglyceridemia. J Am Coll Cardiol 2021.
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| Triglyceride level | Mild-moderate (150–499 mg/dL / 1.7–5.6 mmol/L) |
|---|---|
| ASCVD or high diabetes risk | No |
→Main lineLifestyle-focused + statin by risk
- Lifestyle (first-line)：Mild-moderate (150–499 mg/dL / 1.7–5.6 mmol/L): 5–10% weight loss, limit added sugar and alcohol, limit total fat, ≥ 150 min/week moderate exercise
- Secondary factors：Identify and treat secondary causes (uncontrolled diabetes, hypothyroidism, kidney disease, certain drugs)
- Statin：Statin by ASCVD risk (10-year risk ≥ 7.5% or elevated LDL); statins lower both TG and cardiovascular events
| Triglyceride level | Severe (≥ 500 mg/dL / ≥ 5.6 mmol/L) |
|---|---|
| ASCVD or high diabetes risk | Yes |
→Main lineFibrate for pancreatitis prevention + very-low-fat diet
- Pancreatitis prevention (priority)：Severe (≥ 500 mg/dL / ≥ 5.6 mmol/L): first-line fibrate (fenofibrate, preferred over gemfibrozil when combined with a statin) to lower TG and prevent acute pancreatitis; do not use a statin alone; first target is to lower TG to < 500
- Lifestyle：Very-low-fat diet (≥ 1000 mg/dL: fat 10–15% of intake; 500–999: 20–25%), alcohol cessation, limit refined carbs/added sugar; weight loss; regular exercise
- Secondary factors：Identify and treat secondary causes (especially uncontrolled diabetes, hypothyroidism, certain drugs, alcohol use) — often markedly lowers TG
Frequently asked questions
- What is Hypertriglyceridemia Management?
- This tool directs hypertriglyceridemia management by triglyceride level and ASCVD risk, distinguishing pancreatitis prevention in severe disease from cardiovascular risk reduction in mild-moderate disease.
- How is Hypertriglyceridemia Management calculated? What is the core formula?
- Severe (≥ 500 mg/dL) → fibrate + very-low-fat diet + treat secondary causes (± ω-3), statin only after TG < 500. Mild-moderate (150–499) → lifestyle + statin by risk; high-risk on statin with TG ≥ 150 → add icosapent ethyl.
- When is Hypertriglyceridemia Management used?
- Use to choose the main line: severe TG (≥ 500 mg/dL) prioritizes a fibrate and very-low-fat diet to prevent pancreatitis, while mild-moderate TG is lifestyle-led with a statin and possible icosapent ethyl.
- What are the key clinical points for Hypertriglyceridemia Management?
- In severe hypertriglyceridemia the goal is preventing acute pancreatitis, so a fibrate (not a statin alone) leads, alongside a very-low-fat diet and secondary-cause treatment. (original synthesis · not guideline verbatim) Icosapent ethyl (REDUCE-IT) lowers major cardiovascular events ~25% in high-risk patients with persistent TG ≥ 150 on a statin. Uncontrolled diabetes, hypothyroidism, alcohol, and certain drugs are common secondary drivers worth correcting first.
- What are the limits and cautions when using Hypertriglyceridemia Management?
- For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
- How is Hypertriglyceridemia Management calculated in practice? Can you show a worked example?
- Inputs: Triglyceride level Mild-moderate (150–499 mg/dL / 1.7–5.6 mmol/L), ASCVD or high diabetes risk No → Result: Main line Lifestyle-focused + statin by risk（Lifestyle (first-line): Mild-moderate (150–499 mg/dL / 1.7–5.6 mmol/L): 5–10% weight loss, limit added sugar and alcohol, limit total fat, ≥ 150 min/week moderate exercise, Secondary factors: Identify and treat secondary causes (uncontrolled diabetes, hypothyroidism, kidney disease, certain drugs), Statin: Statin by ASCVD risk (10-year risk ≥ 7.5% or elevated LDL); statins lower both TG and cardiovascular events） Inputs: Triglyceride level Severe (≥ 500 mg/dL / ≥ 5.6 mmol/L), ASCVD or high diabetes risk Yes → Result: Main line Fibrate for pancreatitis prevention + very-low-fat diet（Pancreatitis prevention (priority): Severe (≥ 500 mg/dL / ≥ 5.6 mmol/L): first-line fibrate (fenofibrate, preferred over gemfibrozil when combined with a statin) to lower TG and prevent acute pancreatitis; do not use a statin alone; first target is to lower TG to < 500, Lifestyle: Very-low-fat diet (≥ 1000 mg/dL: fat 10–15% of intake; 500–999: 20–25%), alcohol cessation, limit refined carbs/added sugar; weight loss; regular exercise, Secondary factors: Identify and treat secondary causes (especially uncontrolled diabetes, hypothyroidism, certain drugs, alcohol use) — often markedly lowers TG）